International Journal of Clinical Research. 2020; 4: (1) 4; DOI: 10.26855/j.ijcr.20200004.
Objective: To study the clinical effects of preoperative prevention of anti-infective drugs and comprehensive measures on reducing perioperative infection in gynecology and obstetrics. Methods: A total of 88 patients who were admitted to our hospital from February 2019 to August 2019 and required gynecological and obstetric surgery were selected as the subjects of this study. Researchers are required to divide these patients into the control group (44 cases) and the observation group (44 cases) according to the touch method. The control group of patients with obstetrics and gynecology uses anti-infective drugs and conventional treatment methods, and the observation group of obstetrics and gynecology Patients were treated with anti-infective drugs and comprehensive treatment before surgery. Nursing staff were needed to keep records during the study period. The treatment efficiency, C-reactive protein, procalcitonin, incision infection, puerperal infection, and length of hospital stay were compared between the two groups. Results: Observation group patients with gynecological and obstetric surgery received anti-infective drugs and comprehensive treatment after treatment with an effective rate of 93.2%, while control group patients with postoperative anti-infection and conventional treatment with an effective rate of 86.4%. The data in the observation group were significantly better than those in the control group, with significant differences between the groups (P <0.05). In addition, the postoperative C-reactive protein (2.62 ± 0.72) ml / L and procalcitonin (2.83 ± 0.84) ng / ml in the observation group of gynecological and obstetric patients were compared with the postoperative C-response of the gynecological and obstetric patients in the control group. The protein (4.21 ± 1.42) ml / L and procalcitonin (5.87 ± 1.32) ng / ml were low. The data comparison was different and had statistical significance (P <0.05). Conclusion : The application of anti-infective drugs and comprehensive treatment for gynecological and obstetric surgery patients before surgery can effectively improve the treatment efficiency and reduce the rate of incision infection, which is worthy of clinical popularization.